New partnerships formed during the Covid-19 era
Global pandemic brings attention to the fast-growing, $125bn vaccine market by 2030Read more here
Biotechnology platforms to enable fast, customisable vaccines
Customisable biotechnology platforms manufacture COVID-19 vaccines faster than traditional methods.Secure your place
New vaccine delivery technologies for better immune response
Clinical trials show delivery of vaccines via new techniques induce greater immune responses.View the latest program
Expert Speakers to Date
- Jasmin Samaras
University College London
- Antonio Roldao
- Philip Probert
Centre for Process Innovation
- Gregory Tobin
- Yongxiu Yao
The Pirbright Institute
- Tom Tillett
- Fredrik Sundberg
- Kevin Killeen
- Anh Wartel
International Vaccine Institute
- Anna Särnefält
- The Pirbright Institute
- VBI Vaccines
- University College London
- Harvard University
- Bill & Melinda Gates Foundation
- Biological Mimetics
- MBF Therapeutics
- Matrivax Corporation
- International Vaccine Institute
- Technical University of Denmark
- CanSino Biologics
Who should attend
- Vaccine Research
- Vaccine Development
- Vaccine Manufacturing
- Vaccine Technologies
- Genetic Engineering
- DNA and mRNA Technologies
- Viral Vector-Based Vaccines
- Nucleic Acid-Based Vaccines
- Vaccine Delivery Platforms
- Biological Engineering of Vaccines
- Structural Vaccinology Projects
- Advanced Live-Attenuated Vaccines
- Inactivated Vaccine Development
- Cost Reduction Strategies
- Sales and Marketing Initiatives
- Business Development
- Clinical Trials and Approvals
- Immunisation Research & Development
- Manufacturing Research & Innovation
- Research and Development
- Strategy, Projects, & Public Affairs
- Legal and Compliance Work
- Equipment Certification Services
- News Reporting and Journalism
The Vaccine Manufacturing Summit 2023 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest vaccine technologies and techniques for developing and manufacturing next-generation vaccines…view more...
Subscribe for updates:
Key topics for 2023:
- The fundamentals of vaccine discovery and development to accelerate innovation
Understand vaccine manufacturers' perspective on sustainable vaccine development through next-generation bioinformatics and deep learning techniques.
- Exploring innovative and disruptive technologies for biologics and vaccine manufacturing
Analyse emerging trends in potential disruptive technology in vaccine formulation, manufacturing, development, and health care delivery.
- Latest research in Quality-by-Design (QbD) analytics for vaccine development
Explore innovations in Quality-by-Design (QbD) approaches in vaccine development and their implementation for the rapid development and deployment of high-volume vaccines.
- Leveraging blockchain technology for vaccine manufacturing and supply chain solutions
Evaluate the blockchain-enabled pharmaceutical cold chain and supply chain transparency through blockchain-based traceability.
- Advances in vaccine processing, vaccination strategies, and thermostability
Hear from leading vaccine developers on vaccine efficiency, stability monitoring technology, and vaccination strategies.
- Case studies, clinical trials, and working with global vaccine manufacturers
Gain insights from leading manufacturers and implement strategies that others in the industry use to ensure successful vaccine delivery.
- Provided a great learning opportunity and served as a very good networking event.
Mike Zimmer (Novartis)
- I loved the show! Very informative conference and a great group of people.
Wensheng Du (GlaxoSmithKline)
- Excellent conference. Very useful information. Well organized event and agenda was very appropriate.
Barry Rosen (Sanofi)
- Highly informational event with lots of opportunities to engage with other people from the field.
Ying Wang (Johnson & Johnson)
- Excellent speaker line up. Showcasing the science and results from across the industry.
Anne Renton (Merck)
- Well organized and great discussions. Networking opportunities were excellent.
Carolyn Dulney (Roche)